Sep 8, 2021 08:00AM
Jul 13, 2021 08:01AM
Jul 13, 2021 08:00AM
Jul 6, 2021 08:05AM
Feb 16, 2021 08:00AM
Oct 22, 2020 09:17AM
Oct 22, 2020 09:15AM InVivo Therapeutics Announces Pricing of $15.0 Million Public Offering
Apr 16, 2020 05:49AM
Apr 15, 2020 07:30PM
Mar 6, 2020 09:17AM
Mar 6, 2020 09:15AM
Nov 21, 2019 08:01AM
Nov 21, 2019 08:00AM
Nov 18, 2019 08:16AM Invivo Therapeutics (NVIV) Announces Proposed Public Offering of Common Stock
Nov 18, 2019 08:15AM
Nov 12, 2019 08:00AM
Oct 22, 2019 08:00AM
Jul 12, 2019 08:00AM
May 29, 2019 08:00AM
Apr 17, 2019 08:06AM
Apr 17, 2019 08:00AM InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold™ in Acute Thoracic Complete Spinal Cord Injury
Apr 1, 2019 08:15AM
Nov 8, 2018 04:30PM
Oct 2, 2018 08:02AM
Oct 2, 2018 08:00AM
Sep 28, 2018 08:05AM
Aug 28, 2018 08:06AM
Aug 28, 2018 08:00AM InVivo Therapeutics Announces Complete 12-Month Data from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold™ in Acute Thoracic Complete Spinal Cord Injury
Aug 7, 2018 04:30PM
May 7, 2018 04:30PM
May 2, 2018 10:36AM
May 2, 2018 08:00AM
Apr 9, 2018 08:00AM
Mar 19, 2018 08:10AM
Mar 19, 2018 08:00AM InVivo Therapeutics Announces Contemporary Thoracic SCI Registry Study (the “CONTEMPO Registry Study”) Findings
Mar 12, 2018 08:15AM
Mar 8, 2018 08:12AM
Mar 8, 2018 08:00AM
Feb 5, 2018 08:00AM
Jan 26, 2018 08:02AM
Jan 26, 2018 08:00AM
Jan 3, 2018 08:02AM Invivo Therapeutics (NVIV) Provides Latest Results from INSPIRE and Provides Update on Proposed Clinical Path Forward
Jan 3, 2018 08:00AM
Dec 18, 2017 08:11AM
Dec 18, 2017 08:00AM
Oct 30, 2017 04:45PM
Aug 28, 2017 04:44PM
Aug 28, 2017 04:30PM
Aug 8, 2017 06:00PM InVivo Therapeutics Provides Business Update and Reports 2017 Second Quarter Financial Results
Jul 31, 2017 08:04AM

323,759 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All